The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I
Open accessAbstract
Luteolin, a naturally occurring flavonoid, is abundant in our daily dietary intake. It exhibits a wide spectrum of pharmacological properties, but little is known about its biochemical targets other than the fact that it induces topoisomerase II-mediated apoptosis. In the present study, we show that luteolin completely inhibits the catalytic activity of eukaryotic DNA topoisomerase I at a concentration of 40μM, with an IC50 of 5μM. Preincubation of enzyme with luteolin before adding a DNA substrate increases the inhibition of the catalytic activity (IC50 = 0.66μM). Treatment of DNA with luteolin before addition of topoisomerase I reduces this inhibitory effect. Subsequent fluorescence tests show that luteolin not only interacts directly with the enzyme but also with the substrate DNA, and intercalates at a very high concentration (>250μM) without binding to the minor groove. Direct interaction between luteolin and DNA does not affect the assembly of the enzyme–DNA complex, as evident from the electrophoretic mobility-shift assays. Here we show that the inhibition of topoisomerase I by luteolin is due to the stabilization of topoisomerase-I DNA-cleavable complexes. Hence, luteolin is similar to camptothecin, a class I inhibitor, with respect to its ability to form the topoisomerase I-mediated ‘cleavable complex'. But, unlike camptothecin, luteolin interacts with both free enzyme and substrate DNA. The inhibitory effect of luteolin is translated into concanavalin A-stimulated mouse splenocytes, with the compound inducing SDS–K+-precipitable DNA–topoisomerase complexes. This is the first report on luteolin as an inhibitor of the catalytic activity of topoisomerase I, and our results further support its therapeutic potential as a lead anti-cancer compound that poisons topoisomerases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47282-6 · Cited by 887
Cited by
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Lin, Y., Shi, R., Wang, X., & Shen, H.-M. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908786241050 · Cited by 1,169
Distribution and biological activities of the flavonoid luteolin
Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106
New horizons in the extraction of bioactive compounds using deep eutectic solvents: A review
Zainal-Abidin, M. H., Hayyan, M., Hayyan, A., & Jayakumar, N. S. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.05.012 · Cited by 637
Flavonoids as prospective compounds for anti-cancer therapy
Ravishankar, D., Rajora, A. K., Greco, F., & Osborn, H. M. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.10.004 · Cited by 572
Brusselmans, K., Vrolix, R., Verhoeven, G., & Swinnen, J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408177200 · Cited by 474
Metadata
- Authors
- CHOWDHURY, A. R., SHARMA, S., MANDAL, S., GOSWAMI, A., MUKHOPADHYAY, S., & MAJUMDER, H. K.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2002-09-01
- Volume
- 366
- Issue
- 2
- Pages
- 653-661
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2070455847
- Cited by
- 185
- References
- 1
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. https://app.cochat.ai/papers/10.1042/bj20020098
- The paper
- CHOWDHURY, A. R., SHARMA, S., MANDAL, S., GOSWAMI, A., MUKHOPADHYAY, S., & MAJUMDER, H. K. (2002). Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochemical Journal. https://doi.org/10.1042/bj20020098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.